Literature DB >> 21147945

The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?

Joellyn M Abraham1, Leslie Cho.   

Abstract

Although evidence suggests that the homocysteine hypothesis is still relevant as a predictor of cardiovascular risk, we cannot conclude that measuring the homocysteine level is useful in guiding treatment. Furthermore, studies of primary and secondary prevention show no evidence that taking folic acid or other B vitamins lowers the risk of cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147945     DOI: 10.3949/ccjm.77a.10036

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  17 in total

1.  The role of iron, omega-3 Fatty acids, and vitamins in heart failure.

Authors:  Donald S Silverberg; Doron Schwartz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 2.  Coronary artery disease in Bangladesh: a review.

Authors:  A K M Monwarul Islam; A A S Majumder
Journal:  Indian Heart J       Date:  2013-07-10

3.  Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent.

Authors:  Daniela Giustarini; Paolo Fanti; Anna Sparatore; Elena Matteucci; Ranieri Rossi
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

4.  Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Elisabetta Baffero; Adriana Garzaniti; Gabriele Pelissero; Silvia Collaviti; Annalisa Grugnetti; Pietro Gallotti; Arturo Pujia; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-10-11       Impact factor: 3.633

5.  The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort.

Authors:  Eytan Cohen; Ili Margalit; Tzippy Shochat; Elad Goldberg; Ilan Krause
Journal:  J Nephrol       Date:  2019-06-05       Impact factor: 3.902

Review 6.  The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.

Authors:  Mark R Hellmich; Ciro Coletta; Celia Chao; Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

7.  The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults.

Authors:  Laura A Da Costa; Paul Arora; Bibiana García-Bailo; Mohamed Karmali; Ahmed El-Sohemy; Alaa Badawi
Journal:  Diabetes Metab Syndr Obes       Date:  2012-10-04       Impact factor: 3.168

8.  Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women.

Authors:  Gül Gürsoy; Sena Ulu; Yaşar Acar; Berrin Demirbaş; Süleyman Alkan; Birsen Erol; Işıl Ozaşık
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

9.  Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis.

Authors:  Ivan V Shirinsky; Valery S Shirinsky
Journal:  Int J Rheumatol       Date:  2011-06-21

Review 10.  Pioglitazone and Endothelial Dysfunction: Pleiotropic Effects and Possible Therapeutic Implications.

Authors:  Miroslav Radenković
Journal:  Sci Pharm       Date:  2014-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.